CVE-2025-64642

HIGHCVSS 7.1/10EPSS 0.10%

Last modified

CVE-2025-64642 is a high-severity vulnerability rated 7.1/10 on the CVSS scale. NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.. EPSS estimates a 0.10% chance of exploitation in the next 30 days.

Description

NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.

Metrics

CVSS 3.1
7.8/10

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

CVSS 4.0
7.1/10

CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

EPSS Probability
0.10%

1.0th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
MirionBiodose\/Nmis< 23.0

References

Timeline

Published
Last Modified
Status
Analyzed

Frequently Asked Questions

What is CVE-2025-64642?
NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.
How severe is CVE-2025-64642?
CVE-2025-64642 has a CVSS score of 7.1/10 (HIGH severity). The EPSS model estimates a 0.10% probability of exploitation in the next 30 days.
How do I fix CVE-2025-64642?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2025-64642?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST